Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Chronic myelomonocytic leukaemia
ADR ID BADD_A00934
ADR Hierarchy
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.04      Myelodysplastic syndromes
01.10.04.004      Chronic myelomonocytic leukaemia
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.04      Myelodysplastic syndromes
16.01.04.004      Chronic myelomonocytic leukaemia
Description Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. [MeSH]
MedDRA Code 10009018
MeSH ID D007951; D015477
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Chronic monocytic leukaemia | Chronic monocytic leukemia | Chronic monocytic leukemia without mention of remission | Chronic myelomonocytic leukaemia | Leukemia monocytic chronic | Monocytic leukaemia, chronic | Monocytic leukemia, chronic | Chronic myelomonocytic leukemia | Chronic monocytic leukaemia without mention of remission | Leukaemia monocytic chronic | Chronic myelomonocytic leukaemia progression | Chronic myelomonocytic leukemia progression | Leukemia, Myeloid | Leukemia, Granulocytic | Myeloid Leukemia | Leukemias, Myeloid | Myeloid Leukemias | Leukemia, Myelogenous | Leukemias, Myelogenous | Myelogenous Leukemias | Myelocytic Leukemia | Myelogenous Leukemia | Granulocytic Leukemia | Granulocytic Leukemias | Leukemias, Granulocytic | Leukemia, Myelocytic | Leukemias, Myelocytic | Myelocytic Leukemias | Leukemia, Monocytic, Chronic | Monocytic Leukemia, Chronic | Chronic Monocytic Leukemia | Chronic Monocytic Leukemias | Leukemia, Chronic Monocytic | Leukemias, Chronic Monocytic | Monocytic Leukemias, Chronic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00194Azacitidine0.001175%
BADD_D00593Decitabine0.000112%
BADD_D00594Deferasirox0.001239%
BADD_D01130Idelalisib0.000112%
BADD_D01136Imatinib0.000168%
BADD_D01253Lenalidomide0.000603%
BADD_D01978Ruxolitinib0.000274%
BADD_D02105Tacrolimus0.000297%
BADD_D02344Vemurafenib0.000112%
BADD_D02345Venetoclax0.000112%
BADD_D02531Avapritinib0.000112%
The 1th Page    1    Total 1 Pages